Before a piece of research can start, sponsors and host institutions need to have appropriate agreements in place. Considerable time and effort can be required to draft different versions of such agreements for the various research scenarios. To simplify this process, the UKCRC Partners and stakeholders have developed a suite of model agreements which can be used “off the shelf”, without modification.
Further details can be found here on the NIHR website.
Report of a workshop on the development of model agreements for commercial collaborative research
Model agreement for non-commercial research in the Health Service developed under the UKCRC umbrella through a consultative process.
The 2011 revised model Clinical Trial Agreement (mCTA) is designed to be used without modification for industry-sponsored trials in patients
The model Clinical Investigation Agreement (mCIA) is designed to be used without modification for company-sponsored commercial research involving medical devices
The Contract Research Organisation model Clinical Trial Agreement (CRO mCTA) is a tripartite agreement between: The pharmaceutical company sponsoring a
The Contract Research Organisation model Clinical Investigation Agreement (CRO mCIA) is a tripartite agreement between: The company sponsoring commercial research
The model Clinical Trial Agreement for pharmaceutical and biopharmaceutical industry sponsored research in primary care (Primary Care mCTA) has been